FIELD: medicine. SUBSTANCE: method involves administration of 0.05-0.2% solution of L-epinephrine in aerosol form by inhalation to patients at acute stage of the disease. The dose is 0.5-10 ml in 1.5-2 h up to improvement onset. Diameter of aerosol particles is 5-25 mcm. The treatment results to decrease of inflammation and upper respiratory ways edema. EFFECT: enhanced effectiveness of treatment. 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF DIAGNOSTICS OF ACUTE STENOSIS STAGE AT ACUTE RESPIRATORY VIRUS DISEASES | 1996 |
|
RU2132633C1 |
| METHOD FOR DIAGNOSING DEGREE OF LARYNX STENOSIS IN CASES OF ACUTE RESPIRATORY INFECTION | 1996 |
|
RU2133104C1 |
| METHOD OF TREATMENT OF PATIENT WITH REACTIVE UROGENIC ARTHRITIS | 1998 |
|
RU2135175C1 |
| METHOD OF TREATING BRONCHOPULMONARY DISEASES | 2018 |
|
RU2695366C1 |
| METHOD OF TREATMENT OF REVERSIBLE ISCHEMIA OF INTER-INTESTINE ANASTHOMOSIS IN PERITONITIS | 2001 |
|
RU2203043C1 |
| METHOD FOR DETERMINATION MODE OF ADRENAL INJURY AT CHILDREN | 1991 |
|
RU2018846C1 |
| METHOD OF TREATING CHRONIC TONSILLITIS IN CHILDREN | 2012 |
|
RU2510742C1 |
| METHOD OF TREATING BRONCHO-OBSTRUCTIVE SYNDROME IN NEWBORNS WITH PNEUMONIA AND TRACHEOBRONCHITIS | 2008 |
|
RU2381040C2 |
| METHOD OF TREATING RHEUMATIC ARTHRITIS | 1997 |
|
RU2164137C2 |
| METHOD FOR TREATING TUBERCULOSIS | 2003 |
|
RU2235537C1 |
